General Electric Company (NYSE:GE) keeping abreast of latest technology with Breast Tomosynthesis
GE healthcare is a General Electric Company (NYSE:GE) unit. It has announced that it has very recently submitted the final-module of its premarket approval application for GE Breast Tomosynthesis, to the U.S FDA. This is an option for the Senographe Essential system. In the final application module, GE Healthcare provided the FDA with all the manufacturing information as well as with its clinical-study results.
The ideal option
This option has been designed as an additional option for GE Breast Tomosynthesis. It will acquire multiple-projection views for 3D Digital Breast Tomosynthesis image outputs. These will be suitable for the diagnosis and screening of breast cancer. The company has a vast Senographe Essential and Care installed-base that is in clinical use in the United States and more than 17,000 Senographe Essentials are currently being used in the country.
When it comes to its Women’s Health Business, the company aims to help clinicians in expanding care to a larger number of women across the world. The company has made humungous efforts in this area since 1965. GE Healthcare’s General Manager, Women’s Health, Prahlad Singh said that the company continues to make progress in providing innovative solutions for breast cancer-detection and diagnosis.
The stage is set
GE has started sending out its first shipments to Australia, Europe, Latin America and the Middle East. A large number of customer orders have been flowing in. GE Healthcare provides numerous transformational medical services and technologies to meet demand for enhanced quality, increased access and affordable healthcare across the world. GE (NYS: GE) works on things that matter – great people and technologies taking on tough challenges.
Healthcare has been a top priority for the company. Recently, GE Capital, Healthcare Financial Services which is a General Electric Company (NYSE:GE) operating unit acted as a lender and an administrative agent in the closing of a term-loan worth $10M for Skylight Healthcare Systems.